Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia

Published:2006 Issue:10 Volume:107 Page:2408-2416
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Fiegl Michael,Falkner Andreas,Hopfinger Georg,Brugger Stefan,Zabernigg August,Bauer Franz,Haslbauer Ferdinand,Demirtas Dita,Grossschmidt Peter,Tatzreiter Georg,Gastl Günther,Greil Richard,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. Results of First Salvage Therapy for Patients Refractory to a Fludarabine Regimen in Chronic Lymphocytic Leukemia

2. Results of the Fludarabine and Cyclophosphamide Combination Regimen in Chronic Lymphocytic Leukemia

3. The CD52 antigen and development of the CAMPATH antibodies

4. Reshaping human antibodies for therapy

5. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis;Journal of Clinical Medicine;2024-08-29

2. S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal;Multiple Sclerosis and Related Disorders;2022-03

3. Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group;Haematologica;2016-05-19

4. Phase III, randomized study of ofatumumab versus physicians’ choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia;Leukemia & Lymphoma;2016-01-19

5. Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience;American Journal of Hematology;2015-08-14